Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settings.

Journal of clinical microbiology - 19 Feb 2025

Desai Kanan T, Ajenifuja Kayode O, Adepiti Clement A, Inturrisi Federica, Dagnall Casey, Hoffman Amanda C, Egemen Didem, Gage Julia C, Wentzensen Nicolas, de Sanjose Silvia, Schiffman Mark

Abstract excerpt

Human papillomavirus (HPV) genotype predicts cervical cancer risk, and genotyping could help guide the management of HPV positives as part of cervical screening. An isothermal amplification HPV extended genotyping test (ScreenFire HPV RS assay) can assay up to 96 samples/controls in 1 hour plus preparation time. A novel format with pre-aliquoted reagents and an anti-contamination component (Zebra BioDome) could...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervix Uteri
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Molecular Diagnostic Techniques

Share to Nigeria

Share to Nucleic Acid Amplification Techniques

Share to Papillomaviridae

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39745462
DOI: 10.1128/jcm.01639-24
PMCID: PMC11837489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settings.PMID 39745462Read ↗

Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settingsSemantic proximity Read ↗

Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.Semantic proximity Read ↗

A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.Semantic proximity Read ↗

Extended HPV typing as an efficient alternative within HPV-based screening programs.Semantic proximity Read ↗

Assessment of Accuracy and Reliability: Validation trial for a Fluorescent Probe-Based Real-Time PCR Assay Kit in Detecting Human Papillomavirus Nucleic AcidSemantic proximity Read ↗

A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.Semantic proximity Read ↗

The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath mediumSemantic proximity Read ↗

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical ScreeningSemantic proximity Read ↗

Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.Semantic proximity Read ↗

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.Semantic proximity Read ↗

Urinary high-risk HPV DNA detection to enhance cervical cancer screening in developing countriesSemantic proximity Read ↗

Analytical performance of Cervista HPV 16/18 genotyping test for cervical cytology samples.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.